Poster CASE - Heart Failure/Transplantation

1350 - Successful Treatment of Donor-Derived Hepatitis C Virus Infection with Glecaprevir/Pibrentasvir Following Cardiac Re-Transplantation

Presentation Number
1350
Speakers
Session Name
POSTER SESSION 2 - Junior Faculty Case Reports: Heart Failure/Transplantation
Date
Thu, Apr 04, 2019
Time
05:45 PM - 07:00 PM
Authors (listed alphabetically)

Previous Eposter
673 - Safety and Efficacy of Extended-Release Tacrolimus in De Novo Heart Transplant Recipients: Preliminary Results from a Phase-II Trial

Next Eposters
720 - Non-Invasive Venous Waveform Analysis (NIVA) for Monitoring Pulmonary Capillary Wedge Pressure Post-Orthotopic Heart Transplantation: A Proof of Concept Study
1115 - Gender and Spirituality Influence Patient Care Decisions after LVAD
1034 - Immunosuppression and Outcomes in Elderly Lung Transplant Recipients
830 - Lung Transplant Referral Consensus Guidelines for Individuals with Cystic Fibrosis: An Opportunity for Partnerships between CF and Lung Transplant Centers
639 - Validity and Reliability of the Quality of Life with a Left Ventricular Assist Device (QOLVAD) Questionnaire
749 - Relationship of Spiritual Wellbeing and Depressive Symptoms for Patients with a Left-Ventricular Assist Device (LVAD)
1143 - Long- and Short-Term Changes in Serum Creatinine Prior to LVAD Surgery are Associated with Postoperative Outcomes
667 - Can Donor Step Up Pressure Predict Primary Graft Dysfunction in Recipients Post Heart Transplantation?
1000 - Gender Differences in Pre-Transplant Characteristics and Short-Term Clinical Outcomes Post Heart Transplantation
609 - miR-155 Plays an Essential Role in Anti-MHC-Induced Obliterative Airway Disease